AMENDED AND RESTATED SERVICES AGREEMENTAmended and Restated Services Agreement • June 11th, 2019 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJune 11th, 2019 Company Industry JurisdictionThis Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of June 10, 2019, by and among Roivant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“Service Provider”) and Axovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“ASG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTAmended and Restated Services Agreement • December 20th, 2018 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
Contract Type FiledDecember 20th, 2018 Company Industry JurisdictionThis Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of August 20, 2018, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “ Service Provider”), Dermavant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“DSG”), Dermavant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“DSI”), and Dermavant Sciences Ltd., an exempted limited company organized under the laws of Bermuda (“DSL”, and together with DSG and DSI, and any Additional Service Recipient the “Service Recipients” and each a “Service Recipient”).